|

PLL001 or placebo daily subcutaneous injections Clinical Trials

1 actively recruiting trial

Also known as: Poly-L-lysine conjugates with acetate, butyrate, lactate, propionate

Pipeline

Phase 1/2: 1

Top Sponsors

  • PLL TX AUSTRALIA PTY LTD1

Indications

  • Amyotrophic Lateral Sclerosis1
  • ALS1
  • Multiple Sclerosis1

Other1 trial

A Study to Evaluate the Safety, Efficacy, and Pharmacodynamics of PLL001 in ALS Patients
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.